Pascolo; Steve

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pascolo; Steve.The latest application filed is for "minimal messenger rnas and uses thereof".

Company Profile

3.26.67

Pascolo; Steve - Zurich CH
Pascolo; Steve - Tubingen DE
Pascolo; Steve - Zurlch CH
Pascolo; Steve - Tuebingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Minimal Messenger RNAs and uses thereof App 20220307017 - Pascolo; Steve	2022-09-29
RNA-coded antibody Grant 11,421,038 - Hoerr , et al. August 23, 2	2022-08-23
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions Grant 11,369,691 - Von Der Mulbe , et al. June 28, 2	2022-06-28
Method For Producing Rna App 20220154253 - VON DER MULBE; Florian ; et al.	2022-05-19
Method for producing RNA Grant 11,268,157 - Von Der Mulbe , et al. March 8, 2	2022-03-08
Injection Solution For Rna App 20210308238 - HOERR; Ingmar ; et al.	2021-10-07
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions Grant 11,135,312 - Von Der Mulbe , et al. October 5, 2	2021-10-05
Cytotoxic Immunostimulating Particles And Uses Thereof App 20210205447 - PASCOLO; Steve	2021-07-08
Cytotoxic immunostimulating particles and uses thereof Grant 10,980,875 - Pascolo April 20, 2	2021-04-20
Method For Producing Rna App 20200308634 - VON DER MULBE; Florian ; et al.	2020-10-01
Immunostimulating-Toxic RNA In Alkaline Earth Metal Formulation App 20200268895 - Pascolo; Steve	2020-08-27
Particles comprising protamine and RNA in combination with endosome destabilizing agents Grant 10,729,785 - Pascolo	2020-08-04
Method for producing RNA Grant 10,711,315 - Von Der Mulbe , et al.	2020-07-14
Immunostimulating-toxic RNA in alkaline earth metal formulation Grant 10,646,576 - Pascolo	2020-05-12
Stabilised formulations of RNA Grant 10,626,400 - Pascolo	2020-04-21
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions Grant 10,568,972 - Von Der Mulbe , et al. Feb	2020-02-25
Rna-coded Antibody App 20190284260 - HOERR; Ingmar ; et al.	2019-09-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20190134222 - VON DER MULBE; Florian ; et al.	2019-05-09
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions Grant 10,188,748 - Von Der Mulbe , et al. Ja	2019-01-29
Particles comprising single stranded RNA and double stranded RNA for immunomodulation Grant 10,172,960 - Pascolo J	2019-01-08
Methods And Means For Inducing An Immune Response App 20180318436 - PASCOLO; Steve	2018-11-08
Immunostimulating-Toxic RNA In Alkaline Earth Metal Formulation App 20180311366 - Pascolo; Steve	2018-11-01
Cytotoxic Immunostimulating Particles And Uses Thereof App 20180289797 - PASCOLO; Steve	2018-10-11
Method For Producing Rna App 20180282790 - VON DER MULBE; Florian ; et al.	2018-10-04
Injection Solution For Rna App 20180214523 - Hoerr; Ingmar ; et al.	2018-08-02
Method for producing RNA Grant 10,017,826 - Von Der Mulbe , et al. July 10, 2	2018-07-10
Pharmaceutical Composition Consisting Of RNA Having Alkali Metal As Counter Ion And Formulated With Dications App 20180030448 - Pascolo; Steve	2018-02-01
Pharmaceutical composition consisting of RNA having alkali metal as counter ion and formulated with dications Grant 9,771,594 - Pascolo September 26, 2	2017-09-26
Particles Comprising Single Stranded Rna And Double Stranded Rna For Immunomodulation App 20170266301 - Pascolo; Steve	2017-09-21
Immunostimulation By Chemically Modified Rna App 20170211068 - HOERR; Ingmar ; et al.	2017-07-27
Particles Comprising Protamine And Rna In Combination With Endosome Destabilizing Agents App 20170151349 - Pascolo; Steve	2017-06-01
Application of mRNA for use as a therapeutic against tumour diseases Grant 9,655,955 - Hoerr , et al. May 23, 2	2017-05-23
Stabilised Formulations of RNA App 20170136129 - Pascolo; Steve	2017-05-18
Particles comprising single stranded RNA and double stranded RNA for immunomodulation Grant 9,636,414 - Pascolo May 2, 2	2017-05-02
Combination Therapy For Immunostimulation App 20170000870 - HOERR; Ingmar ; et al.	2017-01-05
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160361438 - VON DER MULBE; Florian ; et al.	2016-12-15
Application of mRNA for use as a therapeutic against tumour diseases Grant 9,463,228 - Hoerr , et al. October 11, 2	2016-10-11
Application of mRNA for use as a therapeutic against tumour diseases Grant 9,439,956 - Hoerr , et al. September 13, 2	2016-09-13
Application of mRNA for use as a therapeutic against tumor diseases Grant 9,433,669 - Hoerr , et al. September 6, 2	2016-09-06
Application of mRNA for use as a therapeutic against tumour diseases Grant 9,433,670 - Hoerr , et al. September 6, 2	2016-09-06
Rna-coded Antibody App 20160185840 - HOERR; Ingmar ; et al.	2016-06-30
Rna-coded Antibody App 20160166692 - HOERR; Ingmar ; et al.	2016-06-16
Rna-coded Antibody App 20160166690 - HOERR; Ingmar ; et al.	2016-06-16
Rna-coded Antibody App 20160166691 - HOERR; Ingmar ; et al.	2016-06-16
Rna-coded Antibody App 20160168254 - HOERR; Ingmar ; et al.	2016-06-16
Rna-coded Antibody App 20160152706 - HOERR; Ingmar ; et al.	2016-06-02
Rna-coded Antibody App 20160152691 - HOERR; Ingmar ; et al.	2016-06-02
Rna-coded Antibody App 20160145346 - Hoerr; Ingmar ; et al.	2016-05-26
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160136259 - Von Der Mulbe; Florian ; et al.	2016-05-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160136301 - VON DER MULBE; Florian ; et al.	2016-05-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160136247 - VON DER MULBE; Florian ; et al.	2016-05-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160136243 - Von Der Mulbe; Florian ; et al.	2016-05-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160136263 - Von Der Mulbe; Florian ; et al.	2016-05-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160136258 - Von Der Mulbe; Florian ; et al.	2016-05-19
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20160129105 - VON DER MULBE; Florian ; et al.	2016-05-12
APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES App 20160095912 - HOERR; Ingmar ; et al.	2016-04-07
APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES App 20160095911 - HOERR; Ingmar ; et al.	2016-04-07
APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES App 20160089425 - HOERR; Ingmar ; et al.	2016-03-31
APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES App 20160089426 - HOERR; Ingmar ; et al.	2016-03-31
APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES App 20160089424 - HOERR; Ingmar ; et al.	2016-03-31
APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES App 20160082092 - HOERR; Ingmar ; et al.	2016-03-24
Application of mRNA for use as a therapeutic against tumour diseases Grant 9,155,788 - Hoerr , et al. October 13, 2	2015-10-13
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20150104476 - VON DER MULBE; Florian ; et al.	2015-04-16
Application Of Mrna For Use As A Therapeutic Against Tumour Diseases App 20150030633 - HOERR; Ingmar ; et al.	2015-01-29
Particles Comprising Single Stranded Rna And Double Stranded Rna For Immunomodulation App 20140348924 - Pascolo; Steve	2014-11-27
Pharmaceutical Composition Consisting Of RNA Having Alkali Metal As Counter Ion And Formulated With Dications App 20140004154 - Pascolo; Steve	2014-01-02
Immunostimulation By Chemically Modified Rna App 20130273001 - HOERR; Ingmar ; et al.	2013-10-17
Rna-coded Antibody App 20130195867 - HOERR; Ingmar ; et al.	2013-08-01
Combination Therapy For Immunostimulation App 20120213818 - Hoerr; Ingmar ; et al.	2012-08-23
Application of mRNA for use as a therapeutic agent for tumorous diseases Grant 8,217,016 - Hoerr , et al. July 10, 2	2012-07-10
Transfection Of Blood Cells With Mrna For Immune Stimulation And Gene Therapy App 20120009221 - HOERR; INGMAR ; et al.	2012-01-12
Application Of Mrna For Use As A Therapeutic Against Tumour Diseases App 20110311472 - HOERR; Ingmar ; et al.	2011-12-22
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20110269950 - Von Der Mulbe; Florian ; et al.	2011-11-03
Protamine/rna Nanoparticles For Immunostimulation App 20110123637 - Pascolo; Steve ; et al.	2011-05-26
Pharmaceutical Composition Containing A Stabilised Mrna Optimised For Translation In Its Coding Regions App 20110077287 - VON DER MULBE; FLORIAN ; et al.	2011-03-31
Immunostimulation By Chemically Modified Rna App 20100303851 - HOERR; INGMAR ; et al.	2010-12-02
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS App 20100239608 - VON DER MULBE; FLORIAN ; et al.	2010-09-23
Rna-coded Antibody App 20100189729 - Hoerr; Ingmar ; et al.	2010-07-29
Injection Solution for Rna App 20080267873 - Hoerr; Ingmar ; et al.	2008-10-30
Mrna Mixture For Vaccinating Against Tumoral Diseases App 20080171711 - Hoerr; Ingmar ; et al.	2008-07-17
Combination Therapy for Immunostimulation App 20080025944 - Hoerr; Ingmar ; et al.	2008-01-31
Adjuvant In The Form Of A Lipid-modified Nucleic Acid App 20070280929 - Hoerr; Ingmar ; et al.	2007-12-06
Transfection of blood cells with mRNA for immune stimulation and gene therapy App 20060188490 - Hoerr; Ingmar ; et al.	2006-08-24
Immunostimulation by chemically modified RNA App 20050250723 - Hoerr, Ingmar ; et al.	2005-11-10
Application of mRNA for use as a therapeutic against tumour diseases App 20050059624 - Hoerr, Ingmar ; et al.	2005-03-17
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions App 20050032730 - Von Der Mulbe, Florian ; et al.	2005-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.